Korea

#PatThePeptide TikTok Challenge Sparks Surge in Demand: COSRX's The 6 Peptide Skin Booster Serum Sells Out Across Platforms within One Week

LOS ANGELES, March 19, 2024 /PRNewswire/ -- Within just one week of its launch onMarch 7th, the #PatThePeptide TikTok Challenge has ignited a phenomenal response, resulting in the rapid depletion of COSRX'sThe 6 Peptide Skin Booster Serum

2024-03-20 09:12 1016

NETMARBLE OPENS GLOBAL PRE-REGISTRATION FOR UPCOMING ACTION RPG SOLO LEVELING:ARISE

Early Access Available for Canadian Players Starting March 21 LOS ANGELES, March 19, 2024 /PRNewswire/ -- Netmarble, a leading developer and publisher of high-quality mobile games, opened pre-registration globally for its upcoming mobile and PC gameSolo Leveling:ARISE, and beginning March 21, Ea...

2024-03-20 01:00 1235

SK hynix Begins Volume Production of Industry's First HBM3E

* SK hynix extends success of HBM3, marking first case in industry to mass produce HBM3E * Supply to a customer comes in 7 months after development announced; best-in-class performance to lead level of AI capabilities to world's best * SK hynix to cement position as global top provider of AI...

2024-03-19 10:21 956

Lunit Expands Presence in Europe: to Deliver AI-powered Cancer Screening Solution to France and Portugal

* New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer SEOUL, South Korea, March 18, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diag...

2024-03-18 21:00 1367

/DISREGARD RELEASE: AIMMO Inc/

We are advised by AIMMO Inc that journalists and other readers should disregard the news release, AIMMO Enters Partnership with Mitsubishi Electric for Data Supply, issued13-Mar-2024 over PR Newswire, as the release contained erroneous information. ...

2024-03-15 14:05 2175

Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research

- Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy, paving the way for improved breast cancer molecular subtype analysis for informed decision-making and precision patient care SEOUL, South Korea, March 14, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ...

2024-03-14 21:00 1539

SurplusGLOBAL Leads with Sustainable Value Creation Based on Legacy Semiconductor Equipment at SEMICON China 2024

SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- SurplusGLOBAL (Booth No. N2351), a leader in the legacy semiconductor equipment sector, is set to make a significant impact at SEMICONCHINA 2024. The company, specializing in legacy semiconductor equipment and parts, plans to showcase customized ...

2024-03-13 22:00 1422

Update on Lunit's Acquisition of Volpara: New Zealand High Court Initial Approval Secured

- Volpara shareholder meeting to be held on April 12, 2024: Culminating the acquisition journey for Lunit, finalization set for May SEOUL, South Korea, March 13, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

2024-03-13 21:00 1317

AITRICS to Participate in HIMSS USA 2024

- Three consecutive years of participation in HIMSS USA - Showcasing 'VitalCare' which is an AI Solution for Predicting Patient Deterioration. SEOUL, South Korea, March 12, 2024 /PRNewswire/ -- AITRICS (CEO Kwang joon Kim), a company specializing in medical artificial intelligence (AI) technology...

2024-03-12 22:50 1403

STRADVISION Renews ISO 27001 Certification, Solidifying Leadership in Automotive Technology Security

SEOUL, South Korea, March 11, 2024 /PRNewswire/ -- STRADVISION , a trailblazer in the automotive technology sector, proudly announces the successful renewal of its ISO 27001 certification for the fourth consecutive year. This achievement reaffirms STRADVISION...

2024-03-11 23:00 1377

TiumBio to Initiate Phase 2 Trial of TU2218 for Cancer

* TiumBio will pursue three indications for the TU2218 combination clinical trial with pembrolizumab * TU2218 demonstrated a favorable safety and a synergetic effect with immuno-oncology drugs in preclinical studies BOSTON and SEONGNAM, South Korea, March 11, 2024 /PRNewswire/ -- TiumBio Co.,...

2024-03-11 20:00 1120

Wellysis and Artella Solutions Launch Innovative Remote Cardiac Monitoring Service in the US.

SEOUL, South Korea, March 8, 2024 /PRNewswire/ -- Wellysis, a digital healthcare company spun off from Samsung, has announced the launch of remote cardiac monitoring service in the US in partnership with Artella Solutions (ARTELLA). Sepand...

2024-03-08 22:00 2516

Game Backend SaaS BACKND to Showcase at 'GDC 2024', Introduces Enhanced Chat Service

- Game Backend SaaS BACKND to Showcase at 'GDC 2024' with Dedicated Booth - BACKND Server Introduces Upgraded Chat Service to the Global Market SEOUL, South Korea, March 7, 2024 /PRNewswire/ -- AFI, the operator of BACKND, a game backend SaaS platform, announced its participation with a dedicate...

2024-03-07 21:00 1225

EDINT wins iF Award 2024 for Proctormatic, a mobile-based AI proctoring service

DAEJEON, South Korea, March 6, 2024 /PRNewswire/ -- EDINT, an AI EdTech startup, announced onMarch 5th that its mobile-based AI online exam proctoring service, Proctormatic, has won the world-renowned International Forum (iF) Design Award 2024.

2024-03-06 15:25 1797

Neurophet introduces AI-powered brain imaging analysis technology at AD/PD 2024

- Showcases brain imaging analysis technology with key products Neurophet AQUA and Neurophet SCALE PET - Aims to commercialize ARIA analysis and amyloid-positive prediction technology SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company f...

2024-03-04 22:00 1131

KCI, a subsidiary of Samyang Group, won 'Platinum Medal' in EcoVadis ESG Rating, Ranked in the Top 1% worldwide

* Evaluated firstly as a L'Oreal partner in 2013 and achieved the highest rating in 11 years * Efforts to establish an ESG committee, reinforce labor and human rights management, and improve management of partners SEOUL, South Korea, March 4, 2024 /PRNewswire/ -- Samyang Group announced that ...

2024-03-04 21:30 1032

LG OLED AND SHEPARD FAIREY TAKE STREET ART INTO THE DIGITAL REALM

American Street Artist and Social Activist, Shepard Fairey Chooses LG OLED as His Digital Canvas at Frieze LA SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- At Frieze Los Angeles 2024, LG OLED is joining forces with Shepard Fairey, the acclaimed contemporary street artist, social activist and...

2024-03-01 02:00 1622

SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug 'SNB-101' on Pancreatic Cancer

SEOUL, South Korea, Feb. 29, 2024 /PRNewswire/ -- SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced onFeb 27 that the US FDA had granted an orphan drug designation for pancreatic cancer for SNB-101 (API: SN-38), a new polymer nanoparticle drug under development, based on the pre-clinical dat...

2024-02-29 18:09 1176

Gauss Labs and SK hynix Publish the Latest Results on AI-based Semiconductor Metrology Technology at SPIE AL 2024

-  Two joint academic papers on AI-based metrology technology presented -  Gauss Labs's innovative technology improves process control and equipment productivity in semiconductor manufacturing -  Gauss Labs is at the forefront, leading industrial AI efforts to transform the manufacturing industr...

2024-02-29 13:50 1096

Lunit Presents Seven Study Results at ECR 2024: Showcasing AI's Robust Performance in Diverse Clinical Settings

- Lunit to unveil four oral presentations and three poster presentations at ECR 2024, highlighting Lunit INSIGHT's expansive capability, ranging from adaptability in different use cases to the potential to replace a human reader in mammography double-reading settings  SEOUL, South Korea, Feb. 28...

2024-02-28 22:03 1063
123456 ... 98